Cargando…
Comparative Analysis of the Effects of the Anti-VEGF Drug and Glucocorticoid by Injection before the End of Vitrectomy for Proliferative Diabetic Retinopathy
OBJECTIVE: To explore the effects of the anti-VEGF drug and glucocorticoid by injection before the end of vitrectomy for proliferative diabetic retinopathy (PDR). METHODS: Eighty PDR patients who underwent vitrectomy in our hospital (July 2020–June 2022) were selected as the research objects and ran...
Autores principales: | Zhao, Haijin, Li, Xueling, Zhao, Xiahai, Zhang, Qiongfang, He, Wei, Wei, Yanfei, Tang, Xueshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553454/ https://www.ncbi.nlm.nih.gov/pubmed/34721617 http://dx.doi.org/10.1155/2021/1285372 |
Ejemplares similares
-
Retracted: Comparative Analysis of the Effects of the Anti-VEGF Drug and Glucocorticoid by Injection before the End of Vitrectomy for Proliferative Diabetic Retinopathy
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Combined Use of Anti-VEGF Drugs Before and During Pars Plana Vitrectomy for Severe Proliferative Diabetic Retinopathy
por: Sun, Xincheng, et al.
Publicado: (2023) -
Effect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy
por: Demir, Mehmet, et al.
Publicado: (2013) -
Refining vitrectomy for proliferative diabetic retinopathy
por: Chen, San-Ni, et al.
Publicado: (2023) -
Comparison of the adjuvant effect of conbercept intravitreal injection at different times before vitrectomy for proliferative diabetic retinopathy
por: Yang, Zhikun, et al.
Publicado: (2023)